Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and Complications
Enrolling by invitation · Not applicable
Conditions studied: Surgical Site Infections, Stress Hyperglycemia
In brief
This study is to determine if glucose monitoring and treatment in surgical procedures over 2 hours help to decrease the surgical site infection risk and reduce postoperative complications. The study uses a preoperative HgBA1C to place patient into a sliding scale insulin category to be used only if the patient has a blood sugar over 150mg/dL during surgery. This is consistent with the CDC recommendation to keep perioperative glucose below 200 mg/dL in surgical patients. The protocol continues for at least 48 hours to treat stress hyperglycemia in non-diabetic patients, and to closely monitor \& treat glucose levels in diabetic patients.
Key facts
- Study ID
- NCT06765655
- Run by
- St. Peter's Hospital, Albany, NY
- People needed
- 266
- Starts
- 2024-04-09
- Expected to finish
- 2025-01-31
- Last updated by the study team
- 2025-01-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- St. Peter's Hospital — Albany, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.